Ipca Laboratories (NSE: IPCALAB) is a leading pharmaceutical company in India that produces and markets a broad range of prescription and non-prescription drugs, APIs (Active Pharmaceutical Ingredients), and intermediates. The company was founded in 1949 and is headquartered in Mumbai, India. It has a global presence with operations in over 120 countries.
The company has a strong product portfolio that includes anti-malarial, anti-emetic, anti-inflammatory, cardiovascular, anti-diabetic, anti-depressant, and anti-bacterial drugs. Some of its well-known brands include Aralen, Hydroxychloroquine Sulphate, Azithral, and Lariago. In terms of earnings, Revenue from Operations for Q3 FY23 was ₹1,546 crore, a 8% increase from ₹1,430.47 crore in the same period last year. The third quarter’s other income, which contributed ₹30.89 Crore to the Total Revenue. Meanwhile, the Profit Before Tax improved to ₹169.34 Crore from ₹260.66 Crore from the same quarter previous year. The Consolidated Net Profit was ₹107.84 crore, down 45% from ₹196.96 crore in the same quarter last year. This quarter’s earnings per share was ₹4.25.
Most Popular
Cochin Shipyard Ltd (COCHINSHIP) Q4 FY22 Earnings Concall Transcript
Cochin Shipyard Limited (NSE:COCHINSHIP) Q4 FY22 Earnings Concall dated May. 26, 2022 Corporate Participants: Madhu S Nair -- Chairman & Managing Director Jose V J -- Director Finance Analysts: Vastupal Shah
All you need to know about Antony Waste Handling Cell in one article
Can you guess the name of the company that was listed during the IPO frenzy in 2020 and is the second largest player in the Indian municipal waste management industry?
Demystifying the Leading Non-Ferrous Recycling Company of India
“Hey, how is the market doing today?” “Oh!, its falling tremendously since morning” I am sure news like these might be a common topic of discussion for you nowadays. Interestingly,